Shareholder Alert: The Ademi Firm investigates whether PharmChem, Inc. is obtaining a Fair Price for its Public Shareholders
Prnewswireยท2025-07-21 16:00
Core Viewpoint - The Ademi Firm is investigating PharmChem for potential breaches of fiduciary duty and other legal violations related to its transaction with Alcohol Monitoring Systems [1][2]. Group 1: Transaction Details - PharmChem shareholders will receive $3.75 per share in cash as part of the transaction [2]. - The transaction agreement imposes significant penalties on PharmChem for accepting competing bids, which may limit shareholder options [2]. Group 2: Investigation Focus - The investigation is centered on the conduct of PharmChem's board of directors and whether they are fulfilling their fiduciary duties to all shareholders [2].